AI Model Identifies Major Depression From Routine Blood Tests, Study Shows
A recent study published in Nature demonstrates that artificial intelligence can help screen for major depressive disorder (MDD) using routine laboratory test results. The research, conducted across multiple centers, developed a machine learning model that analyzes common blood test data and other standard clinical laboratory measurements to detect patterns associated with depression.
The approach represents a potential shift in mental health diagnostics, as current methods rely heavily on clinical interviews and self-reported questionnaires. By leveraging existing lab data that is already collected during routine medical visits, the AI system may help identify patients who could benefit from further mental health evaluation without requiring additional specialized testing.
Researchers trained and validated the model using data from diverse patient populations across several medical centers, which helps establish the robustness of the findings. The study found that certain laboratory markers, when analyzed together through the AI model, showed meaningful associations with depression status.
The findings suggest that routine laboratory tests—often viewed as unrelated to mental health—may contain subtle biological signals related to depression. This could eventually support healthcare providers in recognizing depression as part of standard medical care, particularly in primary care settings where mental health specialists may not be readily available.
Further validation and clinical studies will be needed before such an approach could be implemented in routine practice, according to the researchers.